Offer - Urjas Oil for just ₹ 1 X
Olmark H 40 Tablet is a commercial drug that is prescribed in the form of Tablet. Secondary and off-label uses of Olmark H 40 Tablet have also been mentioned below.
The correct dosage of Olmark H 40 Tablet depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
The most common side effects of Olmark H 40 Tablet are Upper respiratory tract infection. Apart from the aforementioned side effects, Olmark H 40 Tablet can also lead to other problems, which have been listed below. These side effects of Olmark H 40 Tablet are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Olmark H 40 Tablet is Severe for pregnant women and Mild for women who are breastfeeding. In addition, Olmark H 40 Tablet's effects on the liver, heart and kidney are discussed below in the Olmark H 40 Tablet related warnings section.
Individuals suffering from medical conditions like Asthma, Allergy, Kidney Disease must refrain from the use of Olmark H 40 Tablet since this can cause severe adverse effects. The section on Olmark H 40 Tablet contraindications lists all such conditions.
Drug interactions for Olmark H 40 Tablet have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Olmark H 40 Tablet is not safe while driving, and is is not addictive in nature.
Olmark H 40 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Olmark H 40 Tablet safe for pregnant women?
Olmark H has many dangerous side effects in pregnant women. If you are pregnant, do not consume Olmark H without medical advice.
Is the use of Olmark H 40 Tablet safe during breastfeeding?
Breastfeeding women can take Olmark H as it bears very minor side effects for them.
What is the effect of Olmark H 40 Tablet on the Kidneys?
Olmark H rarely harms the kidneys.
What is the effect of Olmark H 40 Tablet on the Liver?
Olmark H is rarely harmful for the liver.
What is the effect of Olmark H 40 Tablet on the Heart?
Olmark H has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Olmark H 40 Tablet unless your doctor advises you to do so -
Is this Olmark H 40 Tablet habit forming or addictive?
No, you will not get addicted to Olmark H 40 Tablet.
Interaction between Food and Olmark H 40 Tablet
Taking Olmark H 40 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Olmark H 40 Tablet
Consuming Olmark H 40 Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173